A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam

Autor: Cam Phuong Pham, Thi Thai Hoa Nguyen, Anh Tu Do, Tuan Khoi Nguyen, Thi Anh Thu Hoang, Tuan Anh Le, Dinh Thy Hao Vuong, Dac Nhan Tam Nguyen, Van Khiem Dang, Thi Oanh Nguyen, Van Luan Pham, Minh Hai Nguyen, Thi Huyen Trang Vo, Hung Kien Do, Ha Thanh Vu, Thi Thuy Hang Nguyen, Van Thai Pham, Le Huy Trinh, Khac Dung Nguyen, Hoang Gia Nguyen, Cong Minh Truong, Tran Minh Chau Pham, Thi Bich Phuong Nguyen

Publikováno v: BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)

Abstract Background This study aimed to evaluate the efficacy and side effects of first-line afatinib treatment in a real-world setting in Vietnam. Methods This retrospective study was conducted across nine hospitals in Vietnam. Advanced epidermal gr

Externí odkaz: https://doaj.org/article/36865a07e0674f89ab90acac425e34cb

Real-world analysis of afatinib as a first-line treatment for patients with advanced stage non-small-cell lung cancer with uncommon EGFR mutations: a multicenter study in Vietnam.

Autor: Pham, Van Luan, Le, Tuan Anh, Pham, Cam Phuong, Hoa Nguyen, Thi Thai, Do, Anh Tu, Nguyen, Tuan Khoi, Nguyen, Minh Hai, Thu Hoang, Thi Anh, Hao Vuong, Dinh Thy, Tam Nguyen, Dac Nhan, Khiem Dang, Van, Nguyen, Thi Oanh, Trang Vo, Thi Huyen, Do, Hung Kien, Vu, Ha Thanh, Nguyen, Thi Thuy Hang, Pham, Van Thai, Trinh, Le Huy, Dung Nguyen, Khac, Nguyen, Hoang Gia

Publikováno v: Therapeutic Advances in Medical Oncology; 5/9/2024, p1-11, 11p

Assessment of the Fanconi anemia repair pathway as a predictor of clinical activity of pembrolizumab (PEM)

Autor: Siddhartha A. Venkatappa, John Paul Diaz, Gail Walker, Zuanel Diaz, Alfredo Pedro Alonso, Miguel A. Villalona-Calero, Santiago Aparo, Muni Rubens, Sara M. Garrido, Sebastian Cuitiva, Hao Vuong, Eric Schroeder, Wenrui Duan, Federico Albrecht, Victor Guardiola, Michael B. Troner, Fernando I. De Zarraga, Troy Antony Gatcliffe

Publikováno v: Journal of Clinical Oncology. 37:2555-2555

2555 Background: Given the activity of immune checkpoint inhibitors (ICI) in mismatch repair deficient tumors, we evaluated if homologous recombination repair deficiency associates with solid tumor response to ICI. Methods: We conducted a phase 2 tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb1a0903adfba38a8d18109fec026937
https://doi.org/10.1200/jco.2019.37.15_suppl.2555

FOLFOXIRI for First-Line Treatment of Unresectable Colorectal Cancer with Liver Metastases in a Resource-Limited Setting.

Autor: Hao VDT; Chemotherapy Department, Cancer Center, Cho Ray Hospital, Ho Chi Minh City, Vietnam., Tri PM; Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Hepato-Pancreato-Biliary Surgery Department, Cho Ray Hospital, Ho Chi Minh City, Vietnam., My DT; Hepato-Pancreato-Biliary Surgery Department, Cho Ray Hospital, Ho Chi Minh City, Vietnam., Anh LT; Chemotherapy Department, Cancer Center, Cho Ray Hospital, Ho Chi Minh City, Vietnam., Trung LV; Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Digestive Surgery Department, Cho Ray Hospital, Ho Chi Minh City, Vietnam., Bac NH; Department of General Surgery, Faculty of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Gastro-Intestinal Surgery Department, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam., Vuong NL; Department of Medical Statistics and Informatics, Faculty of Public Health, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang, Ward 11, District 5, Ho Chi Minh City, Vietnam. nguyenlamvuong@ump.edu.vn.

Publikováno v: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2024 Oct 31; Vol. 56 (1), pp. 12. Date of Electronic Publication: 2024 Oct 31.